PMID: 11333289May 3, 2001Paper

Recent trends in cutaneous melanoma incidence among whites in the United States

Journal of the National Cancer Institute
A JemalM A Tucker

Abstract

It is not yet clear whether increasing melanoma incidence is real or whether recent incidence trends mainly reflect improved diagnosis. To address this question, we examined the most recent melanoma incidence patterns among the white population stratified by sex, age, tumor stage, and tumor thickness by use of data from the Surveillance, Epidemiology, and End Results Program. We examined log-transformed age-specific rates for melanoma by 5-year age groups and time periods by year of diagnosis and birth cohort. Melanoma trends were further examined among broader age groups (<40 years, 40-59 years, and > or =60 years) by tumor stage and tumor thickness. Rates were age-adjusted to the 1970 U.S. standard population, and trends were tested by use of a two-sided Student's t test. Melanoma incidence increased in females born since the 1960s. From 1974-1975 through 1988-1989, upward trends for the incidence of localized tumors and downward trends for the incidence of distant-stage tumors occurred in the age group under 40 years. In the more recent time period, 1990-1991 through 1996-1997, age specific rates among females compared with males generally remained stable or declined more for distant-stage tumors and increased less for local...Continue Reading

References

Nov 1, 1991·Cancer Causes & Control : CCC·T M Mack, B Floderus
Oct 21, 1991·International Journal of Cancer. Journal International Du Cancer·J ScottoJ A Lee
Feb 20, 1991·International Journal of Cancer. Journal International Du Cancer·E P van der EschW B Essex
Sep 15, 1988·International Journal of Cancer. Journal International Du Cancer·A OsterlindO M Jensen
Jun 15, 1983·International Journal of Cancer. Journal International Du Cancer·K R CookeJ Fraser
Feb 15, 1995·American Journal of Epidemiology·S S DevesaT Fears
Mar 1, 1993·Cancer Causes & Control : CCC·L K DennisJ A Lee
Jan 1, 1996·American Journal of Epidemiology·R E Tarone, K C Chu
Jun 1, 1996·Journal of the American Academy of Dermatology·H K KohR A Lew
Jun 1, 1997·Mayo Clinic Proceedings·R A Swerlick, S Chen
Aug 1, 1997·Journal of the American Academy of Dermatology·J K RobinsonR A Amonette
Oct 31, 1997·Journal of the American Academy of Dermatology·L A MerlinoC F Lynch
Jan 28, 1999·Journal of the American Academy of Dermatology·H I HallB Bewerse
Feb 25, 1999·Bulletin du cancer·F J Lejeune
Apr 29, 1999·The New England Journal of Medicine·B A GilchrestM Yaar
Jan 29, 2000·Statistics in Medicine·H J KimD N Midthune

❮ Previous
Next ❯

Citations

Feb 17, 2010·Archives of Surgery·Mark B FariesDonald L Morton
Aug 16, 2011·Japanese Journal of Ophthalmology·Shiu Ting MakRaymond Kwok-Kay Tse
Jan 18, 2006·Cancer Causes & Control : CCC·Michael CooryIan Ring
Sep 27, 2005·Cancer Causes & Control : CCC·Sally L GlaserDee W West
Jun 13, 2009·Journal of Behavioral Medicine·Nadine A KasparianBettina Meiser
Apr 18, 2006·Current Treatment Options in Oncology·Marie-France Demierre
May 23, 2012·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Beth A GlennKatherine Chen
Sep 21, 2002·Lancet·Rona M MacKieUNKNOWN Scottish Melanoma Group
Jul 18, 2002·American Journal of Preventive Medicine·Mona SaraiyaRobert J Uhler
Jun 27, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E de VriesUNKNOWN Working Group of Regional Cancer Registries
Jul 11, 2003·Parkinsonism & Related Disorders·Katherine H FialaBala V Manyam
Mar 27, 2003·Trends in Molecular Medicine·Glenn Merlino, Frances P Noonan
Feb 10, 2010·Nature Reviews. Clinical Oncology·Susan TsaiJulie Lange
Apr 23, 2002·The British Journal of Dermatology·Thomas L Diepgen, V Mahler
Apr 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·B S CarterP C Walsh
Jun 22, 2010·Journal of Toxicology and Environmental Health. Part a·Gelcio L Q MendesSergio Koifman
Jun 9, 2010·Journal of Evidence-based Social Work·Jonathan Matusitz, Gerald-Mark Breen
May 3, 2007·Human Gene Therapy·Yu-Ching LinDavid M Jablons
Feb 3, 2007·Current Opinion in Oncology·Allan C Halpern, Jocelyn A Lieb
Nov 27, 2008·The American Journal of Surgical Pathology·Janis M TaubeWilliam H Westra
Dec 4, 2012·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Howard W Rogers, Brett M Coldiron
Dec 15, 2010·Photochemistry and Photobiology·André A FernandezDavid L Mitchell
Mar 21, 2008·Pigment Cell & Melanoma Research·Tobias Schatton, Markus H Frank
Apr 17, 2009·Pigment Cell & Melanoma Research·Silke KuphalGlen M Boyle
Oct 24, 1992·BMJ : British Medical Journal·A W Kelsall
Sep 24, 1999·Journal of Epidemiology and Community Health·J LlorcaM Delgado-Rodríguez
Oct 21, 2010·Physiological Genomics·Jaideep BanerjeeChandan K Sen
Dec 20, 2012·Journal of Skin Cancer·David M MarcusJonathan J Beitler
Feb 26, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Gabriella AndreottiAnn W Hsing
Jun 18, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Hongyu WuSusan S Devesa
Mar 4, 2011·Cancer Prevention Research·Chin-Ying ChungGavin P Robertson
Oct 2, 2004·Dermatology : International Journal for Clinical and Investigative Dermatology·Pascale QuatresoozGérald E Piérard
Jun 19, 2008·World Journal of Surgical Oncology·Kaiyumars B ContractorHemant Singhal
Nov 6, 2013·Journal of Translational Medicine·Justin RendlemanTomas Kirchhoff
Aug 13, 2010·Journal of Experimental & Clinical Cancer Research : CR·Man LiXiulan Zhao
Jan 1, 2004·Hereditary Cancer in Clinical Practice·Tadeusz Debniak
Feb 25, 2006·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Jennifer HayMarianne Berwick
Nov 2, 2006·Biological & Pharmaceutical Bulletin·Naoko Miyano-KurosakiAkio Tomoda
Apr 1, 1993·Environmental Health Perspectives·D L DavisD G Hoel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.